Earum Pharmaceuticals Ltd Share Price & Stock Analysis

Earum Pharmaceuticals Ltd (BSE: 542724) is an Ahmedabad, Gujarat-based company in the Pharmaceuticals industry. With a market capitalisation of ₹0 Cr, it ranks #5,323 by market cap among the 6,197 Indian listed companies on FinBizNet, and #61 of 63 in Pharmaceuticals. At ₹0.19 (as of 16 Nov 2026), the share price is 74.0% below its 52-week high of ₹0.73 and 0.0% above its 52-week low of ₹0.19. The share price is down 70.3% over one year and up 0.0% over three months.

Key Metrics

Current Price₹0.19
Market Cap₹0 Cr
BSE Code542724
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio4.8
Return on Equity5.69%
Return on Assets1.63%
52-Week Range₹0.19 – ₹0.73
1-Year Price Change-70.3%
3-Month Price Change0.0%
Beta (1Y)0.05
HeadquartersAhmedabad, Gujarat
Websitewww.earumpharma.com

Latest Quarterly Results — Q1 FY26

Revenue₹0 Cr
Net Profit₹-0 Cr
Net Margin-104.3%
EPS (Basic)₹0.00
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

About Earum Pharmaceuticals Ltd

Murae Organisor Limited engages in the trade in agriculture activities in India. The company was formerly known as Earum Pharmaceuticals Limited and changed its name to Murae Organisor Limited in November 2023. Murae Organisor Limited was incorporated in 2012 and is based in Ahmedabad, India.

Products and Services

1. Pharmaceuticals Intermediates-This segment engages in the manufacture, marketing, trading, and distribution of a range of pharmaceutical formulation products.

Business Segments

1. Trading in Agriculture Activities-100%

Earum Pharmaceuticals Ltd vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Earum Pharmaceuticals Ltd₹0 Cr4.85.69%₹0 Cr-70.3%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Earum Pharmaceuticals Ltd?

Earum Pharmaceuticals Ltd is trading at ₹0.19, with a market capitalisation of ₹0 Cr.

Which sector does Earum Pharmaceuticals Ltd belong to?

Earum Pharmaceuticals Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Earum Pharmaceuticals Ltd?

Earum Pharmaceuticals Ltd has a P/E of 4.8 and a return on equity of 5.69%.

What is the stock symbol of Earum Pharmaceuticals Ltd?

Earum Pharmaceuticals Ltd is listed on the BSE under the scrip code 542724.

How has Earum Pharmaceuticals Ltd's share price moved over the past year?

Earum Pharmaceuticals Ltd's share price is down 70.3% over one year and up 0.0% over three months. Its 52-week range is ₹0.19 to ₹0.73.

What were Earum Pharmaceuticals Ltd's latest quarterly results?

In Q1 FY26, Earum Pharmaceuticals Ltd reported revenue of ₹0 Cr and net profit of ₹-0 Cr, with basic EPS of ₹0 (standalone, parsed from the company's exchange filing).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.